Standard-of-care Chlamydia treatment with azithromycin or doxycycline eradicates Mycoplasma genitalium coinfections in most ...
Review finds disparity in presumptive chlamydia and gonorrhea treatment rates despite CDC guidelines
A Regenstrief Institute-led review of studies on proactive health services for chlamydia and gonorrhea has found that rates of presumptive treatment—antibiotics prior to laboratory test ...
Chlamydia is one of the most commonly diagnosed sexually transmitted infections (STIs) in the UK, yet its symptoms often remain unnoticed. Known as a “silent” infection, it can go undetected for weeks ...
Chlamydia is often called a “silent infection” because many people don’t know they have it. It’s caused by a type of bacteria called Chlamydia trachomatis and can affect both men and women. While it’s ...
This is a preview. Log in through your library . Abstract The susceptibility of Chlamydia trachomatis to antibiotics was studied in vitro and in patients with nongonococcal urethritis. The minimal ...
This is a preview. Log in through your library . Abstract Background and Objectives: Single dose regimens have advantages in the treatment of STD. Azithromycin has unique pharmacokinetics that may ...
Chlamydia trachomatis remains a major global pathogen causing both ocular and genital infections, contributing significantly to public health burdens such as infertility, pelvic inflammatory disease, ...
Kenya is reporting a high burden of curable sexually transmitted infections, a study by the Kenya Medical Research Institution (Kemri) has revealed. Chlamydia is the leading sexually transmitted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results